Skip to main content
. 2008 Nov;154(2):209–215. doi: 10.1111/j.1365-2249.2008.03744.x

Table 1.

Pertinent clinical data and gene expression levels in normal females and in untreated and treated female patients with Graves' disease. TRAk, TSH receptor autoantibodies in serum. Heg = a poly A(−) RNA transcript gene related to thyroid receptor autoantibodies.

Age Years Mean range Sex ♀ TRAk Median ± range IU/l Heg amol/µg total RNA Heg amol/µg DNA Nucks amol/µg total RNA Nucks amol/µg DNA CD14 amol/µg total RNA CD14 amol/µg DNA Duration Months Median range
Normal subjects 44 10 0·35 ± 0·01 0·15 ± 0·01 3·06 ± 0·17 1·26 ± 0·07 77 ± 12 30 ± 3
27–59
Graves' disease 48 16 10·9 0·29 ± 0·01 0·13 ± 0·01 2·06 ± 0·08 0·94 ± 0·07 62 ± 8 29 ± 4 0
Untreated patients 35–67 2·8–90
Graves' disease 42 15 7 0·32 ± 0·02 0·14 ± 0·01 2·4 ± 0·13 0·97 ± 0·07 73 ± 14 28 ± 5 13
Treated patients 28–52 0·5–114 1–19